Company Search:
Advanced Search
Sponsored Links
Takeda Pharmaceutical Company Limited - ADR Company Snapshot
Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other companies in this sector in UNITED STATES : Eisai Company Limited (2020 sales of $6.42 billion of which 83% was Pharmaceutical Business), CSL Limited ($9.15 billion of which 84% was CSL Behring), and Daiichi Sankyo Company Limited ($9.06 billion of which 93% was Prescription drugs).

Sales Analysis. Takeda Pharmaceutical Company Limited reported sales of $30.38 billion for the fiscal year ending March of 2020. This represents an increase of 60.8% versus 2019, when the company's sales were $18.90 billion.
  Stock Performance Chart for Takeda Pharmaceutical Company Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 18.53
(Figures in U.S. Dollars)
1 Week -1.0%   13 Weeks -1.3%  
4 Weeks 1.0%   52 Weeks 6.9%  
Takeda Pharmaceutical Company Limited - ADR Key Data:
  Ticker: TAK Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 30,377,665,240
(Year Ending Jan 2021).
Employees: 47,495
  Currency: U.S. Dollars Market Cap: 57,928,546,223
  Fiscal Yr Ends: March Shares Outstanding: 3,126,203,250
  Share Type: Common Closely Held Shares: 4,497,772
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.